Stallion India Fluorochemicals IPO
LISTEDStallion India Fluorochemicals Ltd · Mainboard IPO · NSE · Pharmaceutical
Price Band
₹85 – ₹90
Issue Size
₹199 Cr
Lot Size
166
Listing Gain
-6.67%
About Stallion India Fluorochemicals Ltd & Business Model
Stallion India Fluorochemicals manufactures and supplies specialty chemicals, particularly refrigerant gases and industrial gases used in HVAC and semiconductor industries.
Business Operations & Revenue Model
Stallion India Fluorochemicals Ltd operates a scalable business model focused on value creation within Pharmaceutical. Revenue is generated through primary product sales, long-term service contracts, B2B distribution networks, and key institutional partnerships. The business leverages automated manufacturing facilities, strict quality control systems, and strategic sourcing to maintain competitive margins and reliable service delivery.
Products & Key Services
1. Core Product & Service Offerings: Comprehensive product lines engineered for Pharmaceutical standards. 2. Customized Solutions: Bespoke product configurations designed to meet specific B2B and institutional client specifications. 3. After-Market & Value-Added Services: Dedicated maintenance, technical support, and supply chain fulfillment services.
Promoters & Corporate Leadership
Stallion India Fluorochemicals Ltd is led by experienced promoters with extensive industry track records and strategic governance capabilities. The leadership team brings multi-decade experience across operations, commercial strategy, corporate administration, and fiscal management.
Objects of the Issue (IPO Objectives)
The company proposes to utilize ₹160.00 Cr for the following primary objectives: 1. Funding capital expenditure requirements for expanding operational infrastructure and technology upgrades. 2. Meeting working capital requirements to support continuous business expansion. 3. Prepayment or repayment of certain outstanding borrowings to optimize capital structure. 4. General corporate purposes and strategic growth initiatives.
IPO Details & Terms
Strengths & Risks
✅ Strengths
- •Established market presence and strong brand recognition in Pharmaceutical.
- •Integrated operational capabilities with focus on quality assurance and efficiency.
- •Diversified customer base reducing revenue concentration risk.
- •Experienced promoter and management team with strong domain expertise.
- •Scalable operational architecture positioned for future expansion.
⚠️ Risks
- •Fluctuations in key raw material availability and pricing could impact gross operating margins.
- •Dependency on third-party logistics and supply chain partners for timely distribution.
- •Intense market competition from both domestic established players and new entrants in Pharmaceutical.
- •Regulatory changes or macroeconomic shifts affecting industry demand cycles.
- •Working capital intensive business operations requiring consistent cash flow management.
🚀 Opportunities
- •Expansion into high-growth regional and export markets.
- •Introduction of innovative product lines targeting evolving customer preferences in Pharmaceutical.
- •Operational efficiency improvements through increased automation and digital integration.
Frequently Asked Questions
What is Stallion India Fluorochemicals IPO?
Stallion India Fluorochemicals IPO is an IPO by Stallion India Fluorochemicals Ltd (Pharmaceutical sector). The issue price is ₹85 – ₹90 with a lot size of 166 shares.
What is the minimum investment for Stallion India Fluorochemicals IPO?
The minimum investment for Stallion India Fluorochemicals IPO is approximately ₹14,940 (1 lot of 166 shares at ₹90 upper price band).
When is the Stallion India Fluorochemicals IPO allotment?
The allotment date for Stallion India Fluorochemicals IPO is 21 Jan 2025.
When does Stallion India Fluorochemicals IPO list?
Stallion India Fluorochemicals IPO is scheduled to list on 23 Jan 2025.
Key Dates
IPO Rating
Check Allotment Status
Verify your allotment on the official registrar website. Never share OTP or passwords.
Check on Bigshare Services Pvt Ltd →GMP (Grey Market Premium) is an unofficial, unregulated indicator. It does not guarantee the listing price. All IPO information is for educational purposes only. Verify from official SEBI/NSE/BSE sources.